Application no. and date | 04798705.2 (espacenet) (Federated) (European Patent Register), 20041130 | Patent/reg. no. and date | DK/EP 1684736, 20110824 | Publication date | 20060802 | Priority no. and date | GB 0327844, 20031201, US 526244 P, 20031201 | EP pub. no. and date |
EP 1684736 20060802 | Effective date | | Applicant/owner | The Institute of Cancer Research, 123 Old Brompton Road
London, Greater London SW7 3RP, GB, Kudos Pharmaceuticals Limited, 1 Francis Crick Avenue Cambridge Biomedical Campus Cambridge CB2 0AA, GB | Applicant ref. no. | 155212 | Inventor | ASHWORTH, Alan, The Breakthrough Breast Cancer Research Centre Institute of Cancer Research 123 Old Brompton Road
London Greater London SW7 3RP, GB, JACKSON, Stephen, c/o AstraZeneca Intellectual Property AstraZeneca R&D Alderley Alderley Park
Macclesfield Cheshire SK10 4TG, GB, MARTIN, Niall, c/o AstraZeneca Intellectual Property AstraZeneca R&D Alderley Alderley Park
Macclesfield Cheshire SK10 4TG, GB, SMITH, Graeme, c/o AstraZeneca Intellectual Property AstraZeneca R&D Alderley Alderley Park
Macclesfield Cheshire SK10 4TG, GB | Representative | AWA Denmark A/S, Strandgade 56, 1401 København K, DK | Opponent | | IPC Class | A61K 31/00 (2006.01) , A61K 31/502 (2006.01) , A61P 35/00 (2006.01) | Title | Inhibitorer af DNA-skadereparation til behandling af cancer | Int. application no. | GB2004005025 | Int. publication no. | WO2005053662 | Related patent (certificate) | | Status | Udløbet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|